{"name":"Amarin Pharma Inc.","slug":"amarin-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQTjc1ZUxSZ3BnZkUyd2JETmpQUm9WbDg5LVFReGdDTV9EbnhfQy1kenBJTWZTQUZjeVpENy1lSVZlVjBYU2loQzRTYkFXUnJDMm9aQVRoWUlnNklWMDFqRWN1WjBzMjA4S2V2blJJZEMwVlhsaDZVWFNEVHFHbHJkLWdOZnNySlhjY0l1Z3lRLWkzTjJtVm1RSHloc21MdXI4WXRIVmxfTmhBUWVZSVZOSGFYRmlvQWRxUkE?oc=5","date":"2026-03-24","type":"pipeline","source":"IPWatchdog.com","summary":"SCOTUS Grants Solicitor General Divided Argument in Hikma Induced Infringement Case - IPWatchdog.com","headline":"SCOTUS Grants Solicitor General Divided Argument in Hikma Induced Infringement Case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNVnhQbllyQVY5a0pvaXRwbDdZLUZRR0kzWVdwbjgxajFuUGoxelRwdEtlWWdxcXkyZnQzNkY0N01JQWpLWG5HYmJvdHBBLS1IX0Zzay1qZXZsUXFrYzM3aEVCNzRNNmJTcDAwQXUwc0d0QWIwenE5d3VHMUtTbFF0NzExX1NDcVIxLWVNUjhscVluUnZIM3hIek5VNWoxbnRXbC1WYVRZbUxhR1BzZGNoQ3hvWjl3bWZaLVc0d9IBckFVX3lxTE15VFFFVFZwOG5oQk44SkdSLVlhdDducE94YXItQUFaTGFHcDNqdEY5NERCTzVEZUtCczRYLU5wVllVcFZ1V1A3ZXJsTHBLUjVxQlEybWVORnFZYldPS3RkaW93ZXFBZE9CTjZqNFJqd3Y3Zw?oc=5","date":"2026-03-24","type":"patent","source":"Law360","summary":"Amarin Tells Justices Hikma Drug Patent Appeal Threatens IP - Law360","headline":"Amarin Tells Justices Hikma Drug Patent Appeal Threatens IP - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPX1NQY2tYYjd5UDRhc0xkMXhfZDRlcVhMMWl3Q0xxX3Bxc3lVa2s1UXdCMFBIcEI2VnNiNlV2UFFHc1czbkZNM2d6c0pvQTd0VzljMHVET3RSa01pTVpuNTM4c1ZHazc3S0ZKZXZzVGRWT290QXZXVmU4MTdXWF93SVdBbzQ2MUFuZ1JXcVp6ZjhMTGpPeE1sMnA1ZUx1U0FHYmpxV2EtZUdPbjhRYjJTVTVJVG9Kdk5kWlpRa0d0UGxaeDlWc2VXSHpISjh0SE95b1JzU252R05WU2M?oc=5","date":"2026-03-23","type":"pipeline","source":"american.edu","summary":"Professor Charles Duan Most Recent Amicus Brief and Upcoming Engagement - american.edu","headline":"Professor Charles Duan Most Recent Amicus Brief and Upcoming Engagement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNQkJDUkFKVExwNTNZWUIzS3FQZzRRaGoyUXZ2MTlORjNxYVJaQ2hsX05UNEIteXE3elo3Tms3MENsYUFFOFhCeGgxZk9qS19CZzZlZ1d3SlpHbG5ybkJxQTBRZVhXMWtoR2RDd29xcWlnaFB4dG5ZbFNxV2RKVkZ4VThUYl9HSEp3bm1NRTV6XzJYN0c1Q0NhYVZTZmdlTmFUeUV4QXpsOW1JTXhJd2xpNVQzOGVnaW_SAbwBQVVfeXFMTmhxY3c4SWp5NjRxZ05yUFFWd29hRC12ZFRVaUJzd2lUQUtkeW1KdlBQbVktcFZyeGdyOEltVE9YMklPaG9HTTZxRThwVi1Qb2UyLTZtb2RQZ0Rsb2Rja3dJaFlwTFVDbXlRcWFBc3VGb2lVZUxBM2RUdFNSRkVhSGg0cFFIQk5mQi1SakY5NWZNLTN4TUVicWQ0bktkZFJyQmJ2bWRwVWlRcU1HMnJUUVdrOTJIcHNJZTdkekU?oc=5","date":"2026-03-04","type":"patent","source":"The National Law Review","summary":"U.S. Supreme Court to Weigh Induced Infringement Case Regarding ‘Generic Version of Vascepa®’ - The National Law Review","headline":"U.S. Supreme Court to Weigh Induced Infringement Case Regarding ‘Generic Version of Vascepa®’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPSGRzLUZkWElDbUhJNFM4TGpGVVpHdFVjQzJRbkxzbjd5cFJqOEsxX1d4UDhwRGtNOFc4azRvajZBTnhoZkYyaGNDNTNoUkwyNlRBUjlBN2x2TmdjNGxGRTRmVS1DN042Y2FncGFMVnFzNWdYdGR5aDU0eEZaSlVLZFZkS0F4QXVIQmQtWHhrZENMbDdTNFZFT0JMUGNNRkR4NVU2WWdRbE82SU41VGUw?oc=5","date":"2026-01-29","type":"regulatory","source":"Buchanan Ingersoll & Rooney","summary":"Client Update: Supreme Court Takes Up Skinny Labels Granting Certiorari in Hikma v. Amarin - Buchanan Ingersoll & Rooney","headline":"Client Update: Supreme Court Takes Up Skinny Labels Granting Certiorari in Hikma v. Amarin - Buchanan Ingersoll & Rooney","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPXzc0ajVHem4xaVRZczlNWDFHNV82SUltOVVFaU1fTWE1NEZsSHdaVUR1clUtcm51bTI4MGpaUnVieWc4T2xRMmQxZlQ2WmxBQWtqQ2hEX1hMUkU3WElZM3phYnB5bDFXQ3l4Nll4cE9oc1VPbE1XLVItaVdiVVhleWhfYXk4bGZobGJ5NGhETldQWmlpNUlGRTItWXluaU9fbVJ6VlM3MXlOSnhpN05mX1A4QXdSWjVqTWc?oc=5","date":"2026-01-27","type":"patent","source":"Yale Law School","summary":"Solomon Center Scholars Illuminate Stakes of Supreme Court Drug Patent Liability Case - Yale Law School","headline":"Solomon Center Scholars Illuminate Stakes of Supreme Court Drug Patent Liability Case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOMDZyV1E0ZHBpb2FQTy11ZG1Remc3bmlCMllfMExzN1l2UHZ0ZzEzVEJJamRwME5IdVhVeW8xZGViWXNBNkdOeEw1RGhwazVmbE00bDJrQ09BbzJyU3JobTBpcHVoTkFrRFJFdVU3ZE9Ubm8yZXhuMk5HOXg4MGFkUUE4a3h6cHM?oc=5","date":"2026-01-21","type":"regulatory","source":"JD Supra","summary":"Supreme Court Takes Up Hikma v. Amarin: Induced Infringement and Skinny Labels in the Crosshairs - JD Supra","headline":"Supreme Court Takes Up Hikma v. Amarin: Induced Infringement and Skinny Labels in the Crosshairs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPc1psbW9mb0QwN0lKRmVQRnRjUFNFSFFIRlZwT3hLMVdrT1NCdUtrbDVFOWZlUWE4OTN6czhaTktrSmhMWFJKSEpKd1B4THJTbV8zWDBpdGtJaDNnRlpEaFowU3NyMU5UZnBHUVFkRG1IUU8yRmlid3I1aXdVeF8wZGR1VE10b0RtSXF1Rl9idGRsQi1oenA5UEtFd3hrYkx2cWhFOUlSR1hxRGE2cW9oT3ZxaC1Wd2Y4NnEzeHNWdXVZdjU3c2Zja1dqZ1JDT3Y0SURTUWJwdjVPaGhXZTZqVTZOTU5TN0JVNjdLSVhpUTBqelJMWi1USVIybzdseWJLN1FrX0Izb2RiQ2dlalVVNV9JTDd1Z0V4SGJ0LWxHTjhkeGM0WTdLUW1n?oc=5","date":"2026-01-20","type":"regulatory","source":"VitalLaw.com","summary":"SUPREME COURT NEWS: Supreme Court agrees to review Hikma’s certiorari petition in ‘skinny label’ induced infringement dispute with Amarin - VitalLaw.com","headline":"SUPREME COURT NEWS: Supreme Court agrees to review Hikma’s certiorari petition in ‘skinny label’ induced infringement di","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPSV9TUE9pVGxva0czNmF1R3BvdVVpbC1ESE51SWpBUWdtNC1ka1JZTkczdE1jd0o1TndIV0tRSUdsaVRPMnJseWtTTzRDSUZGSzZUTGp0VTU5N1dqN0JreWthZ0tZbWgwelNkR3ZOTmFkSVhNY1N0VXhtM1lQZjVzeXpLSGd3YlQtbHMxeDVfZEVkYWh2MGpMNnZnSS1ydkRwTjd3?oc=5","date":"2026-01-16","type":"regulatory","source":"Bloomberg Law News","summary":"Justices to Consider Patent Case on ‘Skinny’ Drug Labels (1) - Bloomberg Law News","headline":"Justices to Consider Patent Case on ‘Skinny’ Drug Labels (1)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1MUHEwRzc2d2luYWdIWlQ4ZUliWWR6QTJRdUZHYmw1dkxOTnZYQkptd0xCOVBjb2hkSGc0MUExRlpVd0g1bjg3M1FIa0pCc2FOVUN6MzlONnhZQzVhTGtTWmJhbnJZeHM2U1dYRUlUWV9XVGRYOWVfOA?oc=5","date":"2026-01-03","type":"patent","source":"Patently-O","summary":"Supreme Court’s January 2026 IP Docket: Hikma Leads a Small but Significant Field - Patently-O","headline":"Supreme Court’s January 2026 IP Docket: Hikma Leads a Small but Significant Field - Patently","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQTjBNdnRvcnBXTk5wbDRMS2JqZkR0UWMzU2FVMENPQ3BUeGFpSnVVLWRpWGVmbjlDSS1nYXBqSXh2b25XMnY1amhVaExiMElfcDFPenloTGMwX0FVczMzVGNqeDhyMkI5ckdFcGh0WVl2cUFSZ1JFS24yWmc3RDRBWV96Tzk0TXBjeGU2NHpreWxYeG1LWGw0ZmZOem5Cb0wtSTd3?oc=5","date":"2025-06-24","type":"pipeline","source":"Fierce Pharma","summary":"Amarin sells heart pill Vascepa's rights in Europe to Recordati amid restructuring bid - Fierce Pharma","headline":"Amarin sells heart pill Vascepa's rights in Europe to Recordati amid restructuring bid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQWGNxR3g1NlgwOG1OcUNJT1hBTGJybWUwd3d1VlIzTGQ3M08wcWgtRV9sRHE0OGdBM2dRQ0tjQlRreFFqblBFYkMzbENUcFRHUUFuLWNzLUQxN2tTYUVvSk5CeW9lWllIY3pnQjhqNXRrY0JPMnB3Vmk3Mkt4X05NLWxvNUY0VG1aNjdpNDl4LW9LY0VXYm44VVoxUDd4aExMbWJBaF9fbTZfUVVqYW5IVnBnVWJ3UzVIR1A5dWI3WDc?oc=5","date":"2025-06-23","type":"regulatory","source":"Jones Day","summary":"U.S. Supreme Court Invites Solicitor General to Submit Briefing on \"Skinny Labels\" - Jones Day","headline":"U.S. Supreme Court Invites Solicitor General to Submit Briefing on \"Skinny Labels\"","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}